19

Shares

FDA sends warning letter to eye-tracking startup SyncThink

Shared by Radhika Narayanan | 0 19 0 | about 2 months ago

Boston-based eye tracking company SyncThink has made major changes to its marketing materials since the FDA objected to its labeling in a warning letter. The letter is dated July 31st; MedCityNews first spotted the missive.

Read More On www.mobihealthnews.com

Categories FDA Health law Startups

Related Post

Links

http://www.mobihealthnews.com/content/fda-sends-warning-letter-eye-tracking-startup-syncthink
http://bit.ly/2x0FS8L
http://bit.ly/2wpbMYO

Places mentioned in this article

Organizations mentioned in this article

Disease mentioned in this article

0 Votes

You must log in to post a comment

0 Comments